Burney Company’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-8,807
Closed -$679K 578
2020
Q4
$679K Buy
+8,807
New +$681K 0.04% 334
2019
Q4
Sell
-3,815
Closed -$261K 471
2019
Q3
$261K Sell
3,815
-7,505
-66% -$504K 0.02% 397
2019
Q2
$899K Sell
11,320
-27,769
-71% -$2.2M 0.05% 273
2019
Q1
$3.28M Sell
39,089
-10,314
-21% -$1.08M 0.2% 152
2018
Q4
$5.82M Buy
49,403
+23,544
+91% +$2.72M 0.41% 77
2018
Q3
$3.12M Buy
25,859
+23,464
+980% +$2.91M 0.19% 156
2018
Q2
$276K Hold
2,395
0.02% 381
2018
Q1
$206K Buy
+2,395
New +$185K 0.01% 398
2013
Q4
Sell
-4,930
Closed -$214K 422
2013
Q3
$214K Buy
+4,930
New +$198K 0.02% 392

Other funds holding USNA

Burney Company's USNA Position: Q1 2021 in Review

Burney Company sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 8,807 shares — an estimated $679K sold.

Burney Company first reported a position in USNA in Q3 2013 and held it in 9 quarters. The position peaked at $5.82M in Q4 2018. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Burney Company reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Burney Company sold 8,807 Usana Health Sciences shares in Q1 2021, an estimated $679K.
  • Burney Company first reported a position in Usana Health Sciences in Q3 2013 and held it in 9 quarters.
  • Burney Company's Usana Health Sciences position peaked at $5.82M in Q4 2018.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Burney Company's 13F filing for Q1 2021, filed 13 May 2021.